Bosutinib 10mg 10mg | Purity Not Available
Adooq Bioscience
Bosutinib (SKI-606) is a tyrosine kinase inhibitor undergoing research for use in the treatment of cancer.
More Information Supplier PageSearch Results
Bortezomib 5mg 5mg | Purity Not Available
Adooq Bioscience
Bortezomib is a highly selective, reversible inhibitor of the 26S proteasome
More Information Supplier PageBortezomib 25mg 25mg | Purity Not Available
Adooq Bioscience
Bortezomib is a highly selective, reversible inhibitor of the 26S proteasome
More Information Supplier PageBortezomib (Velcade) 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
Bortezomib is a highly selective, reversible inhibitor of the 26S proteasome
More Information Supplier PageBortezomib 100mg 100mg | Purity Not Available
Adooq Bioscience
Bortezomib is a highly selective, reversible inhibitor of the 26S proteasome
More Information Supplier PageBortezomib 10mg 10mg | Purity Not Available
Adooq Bioscience
Bortezomib is a highly selective, reversible inhibitor of the 26S proteasome
More Information Supplier PageBosutinib 50mg 50mg | Purity Not Available
Adooq Bioscience
Bosutinib (SKI-606) is a tyrosine kinase inhibitor undergoing research for use in the treatment of cancer.
More Information Supplier PageBrivanib alaninate 10mg 10mg | Purity Not Available
Adooq Bioscience
Brivanib alaninate (BMS-582664) is a dual tyrosine kinase inhibitor of VEGFR and FGFR signaling.
More Information Supplier PageBSI-201 10mg 10mg | Purity Not Available
Adooq Bioscience
BSI-201 is a potent inhibitor of PARP-1 and has been shown to cross the blood-brain barrier.
More Information Supplier Page